As in the management of inflammatory bowel disease, etanercept may not adequately control the uveitis.43 Moreover, as the case numbers are low, a causative role cannot be discerned with the use of anti-TNFα agents in PsA patients who develop uveitis.44 Here, TNF is linked to inflammatory bowel disease.